Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Cross-trial comparisons suggest survodutide may achieve greater absolute weight loss, but differences in trial design, patient populations, and endpoints make direct comparison unreliable
Weight-loss jabs are the latest craze for shedding a few pounds
A retrospective cohort study of 4,373 asthmatic patients who were also being treated with diabetic drugs showed that adult patients with asthma treated by a GLP-1 receptor agonist for their type 2 diabetes mellitus had lower rates of asthma exacerbations than those treated with other anti-diabetic drugs (65)
doi: 10.1200/JCO.2012.44.7888 142 AlgaziAPMuthukumarAHOBrienKLencioniATsaiKKKadafourMet al
US$ 20.81
US$ 29.91
US$ 21.20
US$ 23.36
US$ 29.04
US$ 26.94
